Skip to main content
Steven Larson, MD, Nuclear Medicine, New York, NY, NYC Health + Hospitals / Bellevue

StevenMLarsonMDFACR

Nuclear Medicine New York, NY

Chief of Nuclear Medicine mskcc

Dr. Larson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Larson's full profile

Already have an account?

Education & Training

  • Virginia Mason Franciscan Health
    Virginia Mason Franciscan HealthResidency, Internal Medicine, 1968 - 1970
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1968
  • University of Washington
    University of WashingtonB.A., Zoology, 1959 - 1963

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1986 - Present
  • OR State Medical License
    OR State Medical License 1975 - Present
  • NJ State Medical License
    NJ State Medical License 2006 - 2025
  • NY State Medical License
    NY State Medical License 1988 - 2025
  • WA State Medical License
    WA State Medical License 1969 - 2024
  • MD State Medical License
    MD State Medical License 1972 - 1996
  • American Board of Internal Medicine Internal Medicine
  • American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

  • Benedict Cassen Prize for Research in Nuclear Medicine 2012
  • Castle Connolly Top Doctor 2012
  • New York, Super Doctor 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers  
    Steven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism
  • Bone metastases in castration-resistant prostate cancer: expression on PET and overall survival  
    Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H, Radiology, 1/1/2014
  • Phase II study of lutetium-177 labeled anti-prostate-specific membraneantigen (PSMA) monoclonal antibody J591 for metastatic castration-resistantprostate cancer  
    Tagawa ST, Milowsky MI, Morris MJ, Vallabhajosula S, Christos PJ, Akhtar NH, Goldsmith SJ, Osborne J, Larson SM, Pandit-Taskar N, Scher HI, Bander NH, Nanus DM, Clin Cancer Res, 1/28/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Harnessing the Power of the Atom for the Theranostics of Oncology: Targeted Radiotherapy and diagnosis 
    New Haven, CT - 1/23/2015
  • Tumor Immunology-Multidisciplinary Science Driving Combination Therapy 
    Banff, Alberta, Canada - 1/8/2015
  • Androgen Receptor Imaging Agents 
    Baltimore, MD - 1/4/2015
  • Join now to see all

Press Mentions

  • Steven M. Larson, M.D., Receives SNMMI 2021 Paul C. Aebersold Award
    Steven M. Larson, M.D., Receives SNMMI 2021 Paul C. Aebersold AwardJune 14th, 2021
  • New Nuclear Medicine Approach Shows Potential for Precision Treatment of Solid Tumors
    New Nuclear Medicine Approach Shows Potential for Precision Treatment of Solid TumorsJune 26th, 2018

Grant Support

  • 124i-Cg250 Immunopet Imaging Of Sunitinib Treatment Response In Renal Cell CancerNational Cancer Institute2011
  • Mskcc Center For Molecular Imaging In CancerNational Cancer Institute2008–2011
  • Imaging CoreNational Cancer Institute2008–2011
  • Molecular Imaging Of Castrate- Resistance Metastatic Prostate CancerNational Cancer Institute2008–2010
  • Biophysics And Nuclear MedicineNational Cancer Institute2008–2009
  • Shared Instrument: Focus Micropet: CancerNational Center For Research Resources2005
  • Shared Instrument: Focus MicropetNational Center For Research Resources2005
  • Mskcc Center For In Vivo Molecular Imaging In CancerNational Cancer Institute2003–2005
  • Core--ImagingNational Cancer Institute2002
  • Imaging Markers Of Progression &Response In Prostate CancerNational Cancer Institute2000–2002
  • Core--Pet/Gamma ImagingNational Cancer Institute2000–2002
  • Core--Biophysics And Nuclear MedicineNational Cancer Institute2000–2002
  • Core--Nuclear Medicine CoreNational Cancer Institute1996–1999
  • Monoclonal Antibody Imaging And TherapyNational Cancer Institute1996–1997
  • Small Instrumentation ProgramNational Cancer Institute1989

Professional Memberships

Hospital Affiliations